Diagnostic Accuracy and Confidence of [18F] FDG PET/MRI in comparison with PET or MRI alone in Head and Neck Cancer

[1]  Mithat Gonen,et al.  Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. , 2004, Radiology.

[2]  Andrea Soricelli,et al.  Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients--a hypothesis-generating exploratory study. , 2013, Radiology.

[3]  W. Huda,et al.  Effective doses in radiology and diagnostic nuclear medicine: a catalog. , 2008, Radiology.

[4]  J L Roodenburg,et al.  Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Patrick Veit-Haibach,et al.  Contrast-Enhanced PET/MR Imaging Versus Contrast-Enhanced PET/CT in Head and Neck Cancer: How Much MR Information Is Needed? , 2014, The Journal of Nuclear Medicine.

[6]  A. Han,et al.  Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary. , 2012, Cancer epidemiology.

[7]  Hong-chen Liu,et al.  [The usefulness of FDG-PET in patients with cervical lymphadenopathy]. , 2004, Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology.

[8]  J. Sengupta.  The Nonparametric Approach , 1989 .

[9]  S. Taylor.  Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.

[10]  Dung Kai-cheung,et al.  The Catalog , 2001, Thresholds.

[11]  C. Snyderman,et al.  Head and neck malignancy: is PET/CT more accurate than PET or CT alone? , 2005, Radiology.

[12]  S. Payabvash,et al.  Differentiation of benign from malignant cervical lymph nodes in patients with head and neck cancer using PET/CT imaging. , 2016, Clinical imaging.

[13]  Gaspar Delso,et al.  MR Image Based Approach for Metal Artifact Reduction in X-Ray CT , 2013, TheScientificWorldJournal.

[14]  C. Cuénod,et al.  Tumors of the brain, head and neck , 2007 .

[15]  Ian Law,et al.  Dental artifacts in the head and neck region: implications for Dixon-based attenuation correction in PET/MR , 2015, EJNMMI Physics.

[16]  G. Snow,et al.  Imaging of cervical lymphadenopathy. , 1996, Neuroimaging clinics of North America.

[17]  B Friesen,et al.  The Role of CT and MRI in Suspected Acute Cervical Spine Trauma , 2014 .

[18]  S. Kollias,et al.  PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR system. , 2017, Clinical imaging.

[19]  M. R. Anoop,et al.  The present and future , 2001 .

[20]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[21]  E. Matsusue,et al.  Correlation of apparent diffusion coefficients measured by diffusion-weighted MR imaging and standardized uptake values from FDG PET/CT in metastatic neck lymph nodes of head and neck squamous cell carcinomas. , 2012, Clinical imaging.

[22]  Barton F Branstetter,et al.  Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[23]  M. Huellner,et al.  PET/MR in cancers of the head and neck. , 2015, Seminars in nuclear medicine.

[24]  C. Timon,et al.  Evaluation of the impact of addition of PET to CT and MR scanning in the staging of patients with head and neck carcinomas , 2006, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[25]  Tatsuya Higashi,et al.  Clinical Value of Image Fusion from MR and PET in Patients with Head and Neck Cancer , 2008, Molecular Imaging and Biology.

[26]  Yen-Kung Chen,et al.  Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients. , 2006, Anticancer research.

[27]  S. Mukherji,et al.  Biologic Imaging of Head and Neck Cancer: The Present and the Future , 2012, American Journal of Neuroradiology.

[28]  J. Swartz,et al.  Imaging of cervical lymphadenopathy. , 1997, Seminars in ultrasound, CT, and MR.

[29]  A. Weber,et al.  Malignant tumors of the oral cavity and oropharynx: clinical, pathologic, and radiologic evaluation. , 2003, Neuroimaging clinics of North America.

[30]  G. Shah,et al.  New directions in head and neck imaging , 2008, Journal of surgical oncology.

[31]  H. Hakimzadeh,et al.  Part 1 , 2011 .

[32]  Patrick Veit-Haibach,et al.  Clinical positron emission tomography/magnetic resonance imaging applications. , 2013, Seminars in nuclear medicine.

[33]  Bernd J. Pichler,et al.  Feasibility of simultaneous PET/MR imaging in the head and upper neck area , 2011, European Radiology.

[34]  K. Markou,et al.  National Comprehensive Cancer Network (NCCN) Head and Neck Cancers NCCN Clinical Practice Guidelines in Oncology . 2010. , 2011 .

[35]  J. V. van Engelshoven,et al.  Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. , 2007, European journal of radiology.

[36]  F. Wippold.  Head and neck imaging: The role of CT and MRI , 2007, Journal of magnetic resonance imaging : JMRI.

[37]  M. Schluchter,et al.  Qualitative and Quantitative Performance of 18F-FDG-PET/MRI versus 18F-FDG-PET/CT in Patients with Head and Neck Cancer , 2014, American Journal of Neuroradiology.

[38]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[39]  Karl-Olof Lovblad,et al.  Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[40]  Michael Laniado,et al.  PET/MRI in head and neck cancer: initial experience , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  A. Weber,et al.  Nasopharynx: clinical, pathologic, and radiologic assessment. , 2003, Neuroimaging clinics of North America.

[42]  B. Schmidt,et al.  MR assessment of oral cavity carcinomas. , 2012, Magnetic resonance imaging clinics of North America.

[43]  Michael Laniado,et al.  FDG PET/MR for lymph node staging in head and neck cancer. , 2014, European journal of radiology.

[44]  G. Antoch,et al.  Oncologic PET/MRI, Part 1: Tumors of the Brain, Head and Neck, Chest, Abdomen, and Pelvis , 2012, The Journal of Nuclear Medicine.

[45]  L. Marner,et al.  Hybrid FDG PET/MRI vs. FDG PET and CT in patients with suspected dementia – A comparison of diagnostic yield and propagated influence on clinical diagnosis and patient management , 2019, PloS one.

[46]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[47]  P. Hofman,et al.  Morphological MRI criteria improve the detection of lymph node metastases in head and neck squamous cell carcinoma: multivariate logistic regression analysis of MRI features of cervical lymph nodes , 2008, European Radiology.

[48]  J. Czernin,et al.  18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients , 2016, The Journal of Nuclear Medicine.